Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.1.14 (
SPS
)
813
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The possible presence of a
sucrose-phosphate synthase
(
SPS
) activating/stabilizing factor (SAF) presumably lost during
SPS
purification was investigated. Rice leaf protein extracts were chromatographed in a DEAE-Sephacel column.
SPS
activity of previously purified rice enzyme was enhanced to different extent by aliquots of fractions from such column. The activating capacity could not be replaced by albumin, but was nullified by EDTA. When the fractions were boiled or treated with
TCA
, the activating capacity disappeared suggesting its proteinaceous nature. The presence of 10 microM okadaic acid had no effect on the stimulatory action of SAF on
SPS
denying the possibility to SAF to be a
SPS
-phosphatase. Although it overlaps somehow with sucrose synthase (SS) in DEAE-Sephacel fractions, the activating protein factor and SS eluted separately during Sephadex G-200 chromatography. The activating ability was saturable at a fixed
SPS
concentration and was able to enhance
SPS
activity from other plant sources. Simultaneous studies on the activities of
SPS
and sucrose-phosphate phosphatase (SPP), closely linked to
SPS
, allowed us to suggest that SAF could be SPP. The presence of SAF/SPP did not alter the affinity of
SPS
for its substrates but helped to reverse the Pi inhibition at low Fru-6-P concentrations. We conclude that
SPS
may possibly interact with SPP, contributing to a more effective sucrose synthesis.
...
PMID:Activation of sucrose-phosphate synthase by a protein factor/sucrose-phosphate phosphatase. 883 97